Voyager Therapeutics (VYGR) Receivables - Net (2022 - 2026)
Voyager Therapeutics (VYGR) posted Receivables - Net of $1.5 million for Q1 2026, down 15.16% sequentially from $1.8 million in Q4 2025, and down 7.95% YoY from $1.6 million in Q1 2025.
Voyager Therapeutics (VYGR) Receivables - Net (2022 - 2026) Analysis & Trends
Voyager Therapeutics has reported Receivables - Net for 5 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Receivables - Net fell 7.95% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 7.95% YoY) and the FY2025 annual result came in at $1.8 million, up 19.68% from the prior year.
- Receivables - Net declined to $1.5 million in Q1 2026 per VYGR's latest filing, from $1.8 million in the prior quarter.
- Over five years, Receivables - Net peaked at $80.1 million in Q4 2023 and troughed at $837000.0 in Q1 2024.
- A 5-year average of $12.1 million and a median of $1.7 million in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net slumped 98.12% in 2024, then surged 93.91% in 2025.
- Over 5 years, Receivables - Net stood at $10.0 million in 2022, then surged by 701.5% to $80.1 million in 2023, then plunged by 98.12% to $1.5 million in 2024, then climbed by 17.09% to $1.8 million in 2025, then slipped by 15.16% to $1.5 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $1.5 million, $1.8 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.93 Mn |
| Jun 30, 2026 | 2.93 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 15.95 Mn |
| Sep 30, 2024 | 15.95 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 837,000.00 |
| Mar 31, 2024 | 837,000.00 |